Q: This stock is rocketing higher on q2 financials just released. What do you think of it? Despite the gains, first half 2024 eps of 0.13 is very impressive. Risky name but decent small cap opportunity? Thanks.
5i Research Answer:
NCI is very small and risky, but it has been seeing exceptional growth over the last few...